EX-VIVO PRIMING FOR GENERATING CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR NON-TUMOR ANTIGENS TO TREAT AUTOIMMUNE AND ALLERGIC DISEASE

Details for Australian Patent Application No. 2002308732 (hide)

Owner ORTHO-MCNEIL PHARMACEUTICAL, INC.

Inventors CAI, Zeling,; JACKSON, Michael, R.; PETERSON, Per, A.; SHI, Weixing; KONG, Yan; DEGRAW, Juli

Pub. Number AU-A-2002308732

PCT Number PCT/US02/15341

PCT Pub. Number WO2002/092773

Priority 60/291,300 15.05.01 US

Filing date 13 May 2002

Wipo publication date 25 November 2002

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/291,300 15.05.01 US

1 May 2003 Application Open to Public Inspection

  Published as AU-A-2002308732

4 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002308733-POWER SUPPLY

2002308731-DEPLOYMENT APPARATUS FOR SUPPLE SURGICAL MATERIALS